Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Apix Biosciences NV Aka Apix Biosciences is managing 1 pending office action within the Chemistry & Materials technology area. This matter is assigned to 1 distinct examiner and is located in 1 distinct art unit. The company's current patent prosecution is highly centralized, focusing on a single technical application within the USPTO. This concentration provides an opportunity to develop a deep understanding of the specific examiner's requirements for the 1 pending office action.
RODGERS, ARIEL M is the busiest examiner for the portfolio, holding the active workload. Since the busiest examiner pending count is 1, this examiner is responsible for the company's entire active docket. For the practitioner, this means that the outcome of the current prosecution cycle depends entirely on the interactions within the 1 art unit and the specific feedback from this 1 examiner. Strategy should be tailored to the individual style of RODGERS, ARIEL M to effectively advance the 1 pending office action toward a final resolution in the chemistry and materials sector. This focused approach allows for efficient management of the company's intellectual property assets.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RODGERS, ARIEL M | 1 | 15.4% | +26.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19411209 | BEE NUTRITION | RODGERS, ARIEL M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19411209 | BEE NUTRITION | RODGERS, ARIEL M | — |
| Art Unit | Apps |
|---|---|
| 1792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19411209 | BEE NUTRITION | RODGERS, ARIEL M | 1792 | §102§112 | Final Rejection | — | Pending | Dec 06, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialApix Biosciences NV Aka Apix Biosciences has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ariel M Rodgers has the most, with 1 of Apix Biosciences NV Aka Apix Biosciences's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
